0.00Open89.45Pre Close0 Volume0 Open Interest715.00Strike Price0.00Turnover0.00%IV5.14%PremiumJan 3, 2025Expiry Date50.10Intrinsic Value100Multiplier-2DDays to Expiry39.35Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.55Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet